Pharma Sector News Today

Improved demand in key export markets boosts outlook, pharma companies eye single-digit revenue growth in FY25, despite post-pandemic challenges

You can see from foreign flows perspective that rebound in China is detracting from some of the investment in India. I do not think it changes the longer-term trends, but we are in one of those holding patterns similar to the fourth quarter of 2023.

KARACHI: Pakistan Pharmaceutical Manufacturers Association (PPMA) Chairman Mian Khalid Misbah-ur-Rehman highlighted...

After surviving a financial crisis and with most court cases nearing closure, Fortis Healthcare, under new management, is embarking on an ambitious journey to solidify its position in the industry - Issue Date: Apr 14, 2024

Global equity markets have ended the Financial Year 2023-24 on a higher note. Major global equity benchmarks surged significantly and rose up to 44% this year.

PLI schemes across sectors attracted significant investments by December 2023, notably in pharma and solar industries. While some sectors thrived, others like IT hardware, auto, and textiles faced tepid interest, prompting a review for scheme improvements.

Sandeep Raina is not worried about the market crash. Further small cuts are possible, but its not a bloodbath. Stay invested, the market will revive. Quality midcaps, smallcaps, and largecaps with 20% growth, good ROCE, and cash flows are worth investing. Pharma stocks like Beta Drugs, Kilpest, and Sun Pharma are interesting.

Meghana Malkan believes realty and pharma sectors show potential for trade. She highlights specific stocks to watch, cautions about weak resistance for Nifty, predicts a drop in Bank Nifty, takes a break from PSU sector, and has a mixed view on the IT sector. In the case of IT, she would prefer to really adopt a wait-and-watch approach.

Indian pharma industrys heavy dependence on imports for active pharmaceutical ingredients (API), key starting materials (KSM) and basic chemicals has been rather alarming, highlighting the need for a resolution.

Market access in Russia is complex due to diverse channels and language barriers.